- Benzinga Future Finance
- Posts
- đ§ What Happens When Bitcoin Makes A Golden Cross?
đ§ What Happens When Bitcoin Makes A Golden Cross?
Historical data can show us the way.

Happy Friday!
Bitcoin is about to make a golden cross, and the question on everyoneâs mind is: another leg up or a correction like in previous years?
Donald Trump yesterday hosted the (in)famous Trump memecoin dinner â and Benzinga got exclusive photos from the event.
Plus, donât miss our exclusive opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed. Join us for an inside look at Glucotrack, a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM).
Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes.
TOP STORY
Cryptocurrency analyst Benjamin Cowen warns that while Bitcoin has soared to new all-time highs, it may face a short-term correction following a golden cross expected this week.
In a May 21 podcast, Cowen said that "anytime Bitcoin hits a new all-time high or a new cycle high, itâs worth celebrating. But historically, golden crosses are often followed by 10-15% pullbacks."
He referenced similar setups in 2019, 2020 and 2021, when Bitcoin dipped soon after golden crosses, noting that a 10% retrace would bring BTC back near $100,000, while 15% would test $95,000, both near key moving averages.
Whatâs going to happen this time?
SPECIAL OFFER
Donât miss this exclusive opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed. Join us for an inside look at Glucotrack (NASDAQ: GCTK), a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM).
đ What Youâll Learn:
How CBGM technology worksâand how it could transform life for people with diabetes
The critical role of real-time, continuous blood glucose tracking
Why the current CGM landscape needs a bold new solution
Highlights from Glucotrackâs first-in-human clinical trial
Whatâs next: details on the newly announced long-term clinical study
When: Thursday, 5/29 at 11:00 a.m. EST
Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes. Register now!
This is a paid ad. Please see 17b disclosure here for more information.
QUICK N DIRTY
XRP went higher on the first trading day of CME futures â can this be the next big bull catalyst for XRP?
Shiba Inu is down 4%, and itâs not looking good for the popular memecoin â what is going on?
Dogecoin, on the other hand, is up 2%, and analysts are already talking about the famous $1 level â can it really happen?
FINTECH FOCUS
Amid protests and ethical concerns, President Donald Trump hosted a private dinner for the top buyers of his Official Trump memecoin on Thursday.
Trump landed at his private golf club near Washington, D.C., via helicopter to spend the evening with his VIP guests, including cryptocurrency millionaire and Tron founder Justin Sun, the meme coinâs top holder.
In a series of visuals shared with Benzinga by another invitee, Trump can be seen addressing his guests, with an elegant indoor dining setup, complete with wine glasses, cutlery and a menu card, in the background.
Care to take a peek into Trumpâs memecoin dinner?
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Ring The Bell: Created for market enthusiasts by market enthusiasts, this daily newsletter delivers top stories, fast movers and hot trade ideas straight to your inbox. Subscribe here.
Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.
Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.
Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.
Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuerâs securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.